Jiang Zhong-sheng, Jiang Jian-ning
Department of Infectious Diseases, the First Affilicated Hospital, Guangxi Medical University, Nanning 530021, Guangxi, China.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007 Jul;19(7):412-5.
To compare the clinical value in predicting the prognosis of chronic severe hepatitis between the Child-Turcotte-Pugh (CTP) score and the model for end-stage liver disease (MELD) score.
Fifty-five cases with chronic severe hepatitis were scored by CTP and MELD score systems based on their biochemical and coagulation parameters, and related signs within 24 hours after their admission. The termination date of observation was the 90th day after their admission. The actual survival time were recorded. The comparison scores of CTP/MELD were conducted respectively and compared between the survival group and death group, among different clinical stages of chronic severe hepatitis. The correlation of CTP/MELD score with the clinical stages was analyzed respectively. The survival time, mortality and survival rate were compared respectively among the groups classified by CTP/MELD score according to Kaplan-Meier (K-M) survival curve.
The CTP score and the MELD score in death group were higher than those in survival group (both P<0.01). The CTP and MELD scores in the advanced stage group were also higher than those in the early and middle stage (both P<0.01). The correlation of the MELD score with the stage was higher (r(s) =0.689,P<0.01) than that of the CTP score (r(s)=0.428, P<0.01). The survival time of patients with CTP<12 scores, was longer than with CTP>or=12 scores, and their survival rate was also higher(both P<0.01). When the MELD score lowered, survival time was longer, and survival rate was higher. The survival time, mortality and survival rate showed significant difference among the groups classified by MELD score (<or=28 points, 28-40 points, and >or=40 points, all P<0.01).
The parameters employed in MELD score system are more
and easy to achieve, the score range for patients classification is wider and more practical, and the correlation with the clinical stage is higher than CTP score system, suggesting the MELD score system is better in predicting the prognosis of patients with chronic severe hepatitis than the CTP score system.
比较Child-Turcotte-Pugh(CTP)评分与终末期肝病模型(MELD)评分在预测慢性重型肝炎预后方面的临床价值。
对55例慢性重型肝炎患者在入院后24小时内根据其生化和凝血参数及相关体征进行CTP和MELD评分系统评分。观察终止日期为入院后第90天。记录实际生存时间。分别进行CTP/MELD评分比较,并在生存组和死亡组之间、慢性重型肝炎不同临床分期之间进行比较。分别分析CTP/MELD评分与临床分期的相关性。根据Kaplan-Meier(K-M)生存曲线比较按CTP/MELD评分分组的各组之间的生存时间、死亡率和生存率。
死亡组的CTP评分和MELD评分均高于生存组(均P<0.01)。晚期组的CTP和MELD评分也高于早期和中期(均P<0.01)。MELD评分与分期的相关性(r(s)=0.689,P<0.01)高于CTP评分(r(s)=0.428,P<0.01)。CTP<12分患者的生存时间长于CTP≥12分患者,其生存率也更高(均P<0.01)。当MELD评分降低时,生存时间延长,生存率提高。按MELD评分分组(≤28分、28 - 40分和≥40分)的各组之间生存时间、死亡率和生存率差异有统计学意义(均P<0.01)。
MELD评分系统所采用的参数更易获取,患者分类的评分范围更广且更实用,与临床分期的相关性高于CTP评分系统,提示MELD评分系统在预测慢性重型肝炎患者预后方面优于CTP评分系统。